Detalles de la búsqueda
1.
Synthetic lethality-mediated precision oncology via the tumor transcriptome.
Cell
; 184(9): 2487-2502.e13, 2021 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33857424
2.
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition.
Cell
; 184(3): 596-614.e14, 2021 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33508232
3.
Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Nature
; 616(7957): 563-573, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046094
4.
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(6): 491-503, 2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37272513
5.
Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications.
Mol Cancer
; 23(1): 87, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38702773
6.
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B.
Cancer
; 130(9): 1693-1701, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38165808
7.
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
Cancer
; 130(4): 541-552, 2024 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843249
8.
Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer.
Br J Cancer
; 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729997
9.
PD-L1 expression in resected lung adenocarcinoma: prevalence and prognostic significance in relation to the IASLC grading system.
Histopathology
; 84(6): 1013-1023, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38288635
10.
Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09.
BMC Cancer
; 24(1): 574, 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38724991
11.
Establishment of a patient-specific avatar organoid model derived from endoscopic ultrasonography-guided fine needle biopsy for timely clinical application in pancreatic ductal adenocarcinoma.
Gastrointest Endosc
; 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447660
12.
A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomas.
Cancer
; 129(19): 2966-2974, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246414
13.
Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance.
Mod Pathol
; 36(7): 100184, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37054974
14.
Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma.
J Transl Med
; 21(1): 730, 2023 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37848935
15.
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer.
Eur J Immunol
; 51(4): 956-964, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33506525
16.
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non-small cell lung cancer.
Invest New Drugs
; 40(2): 265-273, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973117
17.
Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor.
Oncology
; 100(4): 228-237, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35196661
18.
Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma.
J Neurooncol
; 156(3): 541-549, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35094201
19.
High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Cancer
; 127(16): 3019-3028, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33826761
20.
MDSC subtypes and CD39 expression on CD8+ T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC.
Eur J Immunol
; 50(11): 1810-1819, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32510574